305 related articles for article (PubMed ID: 16831928)
1. Autoimmunity and bone.
Schwarz EM; Looney RJ; Drissi MH; O'Keefe RJ; Boyce BF; Xing L; Ritchlin CT
Ann N Y Acad Sci; 2006 Apr; 1068():275-83. PubMed ID: 16831928
[TBL] [Abstract][Full Text] [Related]
2. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Looney RJ; Ritchlin CT; Boyce BF; Xing L
Arthritis Rheum; 2004 Jan; 50(1):265-76. PubMed ID: 14730625
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC.
Ishikawa S; Nagai S; Sato T; Akadegawa K; Yoneyama H; Zhang YY; Onai N; Matsushima K
Eur J Immunol; 2002 Jul; 32(7):1881-7. PubMed ID: 12115607
[TBL] [Abstract][Full Text] [Related]
4. Bone and joint destruction in rheumatoid arthritis: what is really happening?
Goldring SR
J Rheumatol Suppl; 2002 Sep; 65():44-8. PubMed ID: 12236623
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells protect from local and systemic bone destruction in arthritis.
Zaiss MM; Frey B; Hess A; Zwerina J; Luther J; Nimmerjahn F; Engelke K; Kollias G; Hünig T; Schett G; David JP
J Immunol; 2010 Jun; 184(12):7238-46. PubMed ID: 20483756
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
Zhang Q; Badell IR; Schwarz EM; Boulukos KE; Yao Z; Boyce BF; Xing L
Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
Boyce BF; Schwarz EM; Xing L
Curr Opin Rheumatol; 2006 Jul; 18(4):427-32. PubMed ID: 16763465
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis.
Binder NB; Puchner A; Niederreiter B; Hayer S; Leiss H; Blüml S; Kreindl R; Smolen JS; Redlich K
Arthritis Rheum; 2013 Mar; 65(3):608-17. PubMed ID: 23280418
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast precursors, RANKL/RANK, and immunology.
Xing L; Schwarz EM; Boyce BF
Immunol Rev; 2005 Dec; 208():19-29. PubMed ID: 16313338
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
Polzer K; Neubert K; Meister S; Frey B; Baum W; Distler JH; Gückel E; Schett G; Voll RE; Zwerina J
Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
[TBL] [Abstract][Full Text] [Related]
11. The TNF-alpha transgenic mouse model of inflammatory arthritis.
Li P; Schwarz EM
Springer Semin Immunopathol; 2003 Aug; 25(1):19-33. PubMed ID: 12904889
[TBL] [Abstract][Full Text] [Related]
12. Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis.
Blüml S; Binder NB; Niederreiter B; Polzer K; Hayer S; Tauber S; Schett G; Scheinecker C; Kollias G; Selzer E; Bilban M; Smolen JS; Superti-Furga G; Redlich K
Arthritis Rheum; 2010 Jun; 62(6):1608-19. PubMed ID: 20155834
[TBL] [Abstract][Full Text] [Related]
13. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB.
Martin E; Capini C; Duggan E; Lutzky VP; Stumbles P; Pettit AR; O'Sullivan B; Thomas R
Arthritis Rheum; 2007 Jul; 56(7):2255-66. PubMed ID: 17599748
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells and interferon-mediated autoimmunity.
Gottenberg JE; Chiocchia G
Biochimie; 2007; 89(6-7):856-71. PubMed ID: 17562353
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal cross-talk between RANKL and interferon-gamma-inducible protein 10 is responsible for bone-erosive experimental arthritis.
Kwak HB; Ha H; Kim HN; Lee JH; Kim HS; Lee S; Kim HM; Kim JY; Kim HH; Song YW; Lee ZH
Arthritis Rheum; 2008 May; 58(5):1332-42. PubMed ID: 18438854
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived cells are responsible for the development of autoimmune arthritis in human T cell leukemia virus type I-transgenic mice and those of normal mice can suppress the disease.
Saijo S; Kotani M; Habu K; Ishitsuka C; Yamamoto H; Sekiguchi T; Iwakura Y
J Immunol; 1999 Nov; 163(10):5700-7. PubMed ID: 10553101
[TBL] [Abstract][Full Text] [Related]
17. The type I IFN system in rheumatoid arthritis.
Conigliaro P; Perricone C; Benson RA; Garside P; Brewer JM; Perricone R; Valesini G
Autoimmunity; 2010 Apr; 43(3):220-5. PubMed ID: 20166872
[TBL] [Abstract][Full Text] [Related]
18. Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue.
Gattorno M; Chicha L; Gregorio A; Ferlito F; Rossi F; Jarrossay D; Lanzavecchia A; Martini A; Manz MG
Rheumatology (Oxford); 2007 Apr; 46(4):657-65. PubMed ID: 17085467
[TBL] [Abstract][Full Text] [Related]
19. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
20. Interplay between interferon and other cytokine systems in bone metabolism.
Takayanagi H; Sato K; Takaoka A; Taniguchi T
Immunol Rev; 2005 Dec; 208():181-93. PubMed ID: 16313349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
